| Active ingredient (INN) |
|---|
| Iohexol |
| Brand names | Omnipaque |
|---|
| Therapeutic category | Auto-created by FDA Drug Enforcement — Full Recall Database scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | GE Healthcare Australia Pty Ltd, GE HEALTHCARE LIMITED, ZENTIVA PHARMA UK LIMITED, FARMAK PHARMACEUTICALS UK LTD |
|---|
| Registrations on file | 28 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Omnipaque | 6.47g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |
| Omnipaque | 37.75g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |
| Omnipaque | 377.5 g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |
| Omnipaque | 323.5 g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |
| IOHEXOL 300MG I/ML SOLUTION FOR INJECTION | 300MG | injection | 🇬🇧 GB | GE HEALTHCARE LIMITED | Active |
| IOHEXOL 350MG I/ML SOLUTION FOR INJECTION | 350MG | injection | 🇬🇧 GB | GE HEALTHCARE LIMITED | Active |
| IOHEXOL 140MG I/ML SOLUTION FOR INJECTION | 140MG | injection | 🇬🇧 GB | GE HEALTHCARE LIMITED | Active |
| IOHEXOL 240MG I/ML SOLUTION FOR INJECTION | 240MG | injection | 🇬🇧 GB | GE HEALTHCARE LIMITED | Active |
| IOHEXOL 300 MG I/ML SOLUTION FOR INJECTION | 300 MG | injection | 🇬🇧 GB | ZENTIVA PHARMA UK LIMITED | Active |
| IOHEXOL 350 MG I/ML SOLUTION FOR INJECTION | 350 MG | injection | 🇬🇧 GB | ZENTIVA PHARMA UK LIMITED | Active |
| IOHEXOL 240 MG I/ML SOLUTION FOR INJECTION | 240 MG | injection | 🇬🇧 GB | FARMAK PHARMACEUTICALS UK LTD | Active |
| Omnipaque | 3.88g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |
| Omnipaque | 5.18g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |
| Omnipaque | 25.9g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |
| Omnipaque | 32.35g | — | 🇦🇺 AU | GE Healthcare Australia Pty Ltd | Active |